The growing prevalence of infectious diseases is driving demand for advanced immunoassay testing methods. ELISA techniques are widely used in detecting disease-related biomarkers and supporting laboratory-based diagnostic procedures.
Market Overview
The Enzyme-Linked Immunosorbent Assay (ELISA) Market was valued at US$ 2.47 billion in 2025 and is projected to reach US$ 4.13 billion by 2034,...
